SINGAPORE (Nov 8): Temasek has acquired a minority stake in Ireland-based designer and manufacturer of aerosol drug delivery systems, Aerogen, through the purchase of a secondary share interest, according to media reports.

However, the financial terms of the transaction were not disclosed.

John Power, founder and CEO of Aerogen, says, “We are excited to realise the growth opportunities this collaboration will bring. Temasek, our partner of choice, has deep global and sector expertise, which will accelerate our market penetration.”

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook